Back
Neurogene Vs. Janux Therapeutics Industry Stock Comparison
Sell
18
NGNE
Neurogene
Last Price:
22.37
Seasonality Move:
32.14%
Sell
34
JANX
Janux Therapeutics
Last Price:
59.86
Seasonality Move:
133.13%
Sell
18
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $24.57. The Score for NGNE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $40.18. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $40.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.12 | Sell |
| Relative Strength Index (14 RSI): | 38.07 | Sell |
| Chaikin Money Flow: | -487776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.56 - 58.04) | Sell |
| Bollinger Bands (100): | (30.62 - 51.16) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.77 | Sell |
| Relative Strength Index (14 RSI): | 27.24 | Sell |
| Chaikin Money Flow: | -1691426 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.18 - 54.98) | Sell |
| Bollinger Bands (100): | (41.61 - 51.41) | Sell |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.03 | Buy |
| 20-day SMA: | 38.5 | Sell |
| 50-day SMA: | 43.11 | Sell |
| 200-day SMA: | 38.53 | Sell |
| 8-day EMA: | 25.38 | Sell |
| 20-day EMA: | 32.53 | Sell |
| 50-day EMA: | 38.97 | Sell |
| 200-day EMA: | 36.82 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.8 | Sell |
| 20-day SMA: | 50.2 | Sell |
| 50-day SMA: | 49.69 | Sell |
| 200-day SMA: | 44.62 | Sell |
| 8-day EMA: | 46.1 | Sell |
| 20-day EMA: | 48.65 | Sell |
| 50-day EMA: | 48.98 | Sell |
| 200-day EMA: | 41.57 | Sell |
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.76 per share.
Neurogene Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||